United States · FDA National Drug Code directory
VORICONAZOLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 40032-038_55941af1-d7bf-494a-b90f-9ef19bc76eba
- Product NDC
- 40032-038
- Form
- SUSPENSION
- Composition / generic term
- voriconazole
- Labeler
- Novel Laboratories, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160601
- Source listing expiry
- 20261231
Source-listed ingredients
- VORICONAZOLE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (40032-038-60) / 75 mL in 1 BOTTLE (40032-038-00) · 40032-038-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →